4//SEC Filing
Nicholson Jonathan 4
Accession 0000899243-21-031642
CIK 0001786255other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 6:20 PM ET
Size
18.5 KB
Accession
0000899243-21-031642
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Transactions
- Conversion
Common Stock
2021-08-02+2,749,995→ 2,749,995 total - Purchase
Common Stock
2021-08-02$15.00/sh+133,334$2,000,010→ 2,883,329 total - Conversion
Series B-1 Preferred Stock
2021-08-02−1,027,741→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (247,308 underlying) - Conversion
Series A-1 Preferred Stock
2021-08-02−10,400,415→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (2,502,686 underlying)
Nicholson Jonathan
Other
Transactions
- Conversion
Common Stock
2021-08-02+2,749,995→ 2,749,995 total - Purchase
Common Stock
2021-08-02$15.00/sh+133,334$2,000,010→ 2,883,329 total - Conversion
Series A-1 Preferred Stock
2021-08-02−10,400,415→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (2,502,686 underlying) - Conversion
Series B-1 Preferred Stock
2021-08-02−1,027,741→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (247,308 underlying)
Transactions
- Conversion
Series B-1 Preferred Stock
2021-08-02−1,027,741→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (247,308 underlying) - Purchase
Common Stock
2021-08-02$15.00/sh+133,334$2,000,010→ 2,883,329 total - Conversion
Common Stock
2021-08-02+2,749,995→ 2,749,995 total - Conversion
Series A-1 Preferred Stock
2021-08-02−10,400,415→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (2,502,686 underlying)
Transactions
- Purchase
Common Stock
2021-08-02$15.00/sh+133,334$2,000,010→ 2,883,329 total - Conversion
Series A-1 Preferred Stock
2021-08-02−10,400,415→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (2,502,686 underlying) - Conversion
Series B-1 Preferred Stock
2021-08-02−1,027,741→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (247,308 underlying) - Conversion
Common Stock
2021-08-02+2,749,995→ 2,749,995 total
Footnotes (4)
- [F1]Includes an additional share of Common Stock as a result of the conversion of Preferred Stock calculated on an aggregate basis of all shares of Preferred Stock held by the holder.
- [F2]On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer.
- [F3]NanoDimension III GP Limited Partnership ("ND III GP") is the general partner of NanoDimension III, L.P. ("ND III LP"). NanoDimension III Management Limited ("ND Management") is the general partner of ND III GP, and possesses the power to direct the voting and disposition of the shares owned by ND III LP and may be deemed to have indirect beneficial ownership of the shares held by ND III LP. Jonathan Nicholson and Richard Coles are the members of the board of directors of ND Management and share voting and dispositive power over the shares held by ND III LP. Each reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of his or its respective pecuniary interest therein.
- [F4]ND III LP acquired additional shares in the Issuer's initial public offering.
Documents
Issuer
Icosavax, Inc.
CIK 0001786255
Entity typeother
Related Parties
1- filerCIK 0001677759
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 6:20 PM ET
- Size
- 18.5 KB